ProCE Banner Activity

Infection Incidence With Upadacitinib in Patients With Rheumatoid Arthritis

Slideset Download
Conference Coverage
In this descriptive analysis, upadacitinib 30 mg was associated with a higher rate of serious and opportunistic infections, including herpes zoster, compared with the 15 mg dose.

Released: July 07, 2020

Expiration: July 06, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Gilead Sciences, Inc.